Primary Sjogren syndrome-related peripheral neuropathy: A systematic review and meta-analysis.
Liampas A, Parperis K, Erotocritou MF, Nteveros A, Papadopoulou M, Moschovos C, Akil M, Coaccioli S, Hadjigeorgiou GM, Hadjivassiliou M, Zis P.
Eur J Neurol. 2023 Jan;30(1):255-265. doi: 10.1111/ene.15555. Epub 2022 Sep 23.
Peripheral nervous system immune-related adverse events due to checkpoint inhibition.
O'Hare M, Guidon AC.
Nat Rev Neurol. 2024 Sep;20(9):509-525. doi: 10.1038/s41582-024-01001-6. Epub 2024 Aug 9.
Herpes zoster: A Review of Clinical Manifestations and Management.
Patil A, Goldust M, Wollina U.
Viruses. 2022 Jan 19;14(2):192. doi: 10.3390/v14020192.
Autonomic Peripheral Neuropathy.
Freeman R.
Continuum (Minneap Minn). 2020 Feb;26(1):58-71. doi: 10.1212/CON.0000000000000825.
Peripheral neuropathies.
Hanewinckel R, Ikram MA, Van Doorn PA.
Handb Clin Neurol. 2016;138:263-82. doi: 10.1016/B978-0-12-802973-2.00015-X.
Oligoclonal bands: clinical utility and interpretation cues.
Carta S, Ferraro D, Ferrari S, Briani C, Mariotto S.
Crit Rev Clin Lab Sci. 2022 Sep;59(6):391-404. doi: 10.1080/10408363.2022.2039591. Epub 2022 Mar 11.
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.
Lees JG, Makker PG, Tonkin RS, Abdulla M, Park SB, Goldstein D, Moalem-Taylor G.
Eur J Cancer. 2017 Mar;73:22-29. doi: 10.1016/j.ejca.2016.12.006. Epub 2017 Jan 16.
Aging and the immune response in diabetic peripheral neuropathy.
Hagen KM, Ousman SS.
J Neuroimmunol. 2021 Jun 15;355:577574. doi: 10.1016/j.jneuroim.2021.577574. Epub 2021 Apr 20.
Diverse cell types establish a pathogenic immune environment in peripheral neuropathy.
Choi J, Strickland A, Loo HQ, Dong W, Barbar L, Bloom AJ, Sasaki Y, Jin SC, DiAntonio A, Milbrandt J.
J Neuroinflammation. 2025 May 23;22(1):138. doi: 10.1186/s12974-025-03459-7.
[Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events].
Suzuki S.
Brain Nerve. 2024 May;76(5):605-611. doi: 10.11477/mf.1416202650.
